Moritaka Jindan Opens Innovative Jintan Laboratory in Nakanoshima Qross
Moritaka Jindan Corporation, an esteemed company with over 130 years of history, has made a significant stride in the healthcare sector by establishing the Jintan Laboratory within the innovative Nakanoshima Qross facility in Osaka. Officially open since January 13, 2026, this laboratory signifies a monumental step in advancing research and development strategies that aim to extend health spans and improve individual well-being through science-based solutions.
The establishment of the Jintan Laboratory arises from a keen understanding of the challenges faced in previous research operations. Historically, Moritaka Jindan's research and development were primarily centered around the Osaka Tech Center, utilizing various external labs based on specific experimental needs. However, this resulted in a fragmented approach that hindered synergy. The decision to create a consolidated research hub at Nakanoshima Qross aims to streamline operations, fostering a collaborative environment that accelerates the development of innovative healthcare products.
This new state-of-the-art laboratory is equipped with a wet lab capable of handling human-derived samples, such as fecal matter, which is essential for conducting relevant and practical research that mirrors actual human intestinal conditions. This capability will augment the company's efforts to pursue deeper insights into gut health, forming the basis for developing evidence that supports their functional ingredients and product lines.
Moritaka Jindan has formulated three strategic pillars that encapsulate the vision of the Jintan Laboratory:
1. Deepening Research and Development: The lab will enable research utilizing human-derived samples, allowing for analyses under realistic conditions that lead to robust evidence accumulation. By continuing to refine technologies and augmenting intellectual property strategies, Moritaka Jindan seeks to enhance its unique value proposition in the healthcare market.
2. Maximizing Synergies: The concentration of R&D resources at the Jintan Laboratory will accelerate the establishment of evidence and product development. The synergy between the company's core brands, such as Bifina and Choutek Series, will be enhanced through collaborative efforts that enable more efficient resource utilization and accelerated development timelines, ensuring a competitive edge in product offerings.
3. Open Innovation and Collaborative Synergy: Positioned within the Nakanoshima Qross, a hub for next-generation healthcare innovations, the Jintan Laboratory will engage in open innovation efforts with various startups and institutions housed within the facility. This collaborative ecosystem fosters cross-industry interactions, which are vital for pioneering unique healthcare solutions that Moritaka Jindan alone might not achieve.
Eiji Ishida, the Executive Officer of R&D, has expressed enthusiasm about the new laboratory's potential. He emphasized that consistent experimentation and foundational research are vital sources of innovation. With a clear mission to enhance people's health and contribute positively to societal development, the Jintan Laboratory is set to challenge the boundaries of healthcare technology. Moritaka Jindan is resolute in its approach, maintaining high standards of dedication and resilience in its pursuit of groundbreaking advances.
Name: Jintan Laboratory
Location: Nakanoshima Qross Mitsui Link Lab, 4-3-51 Nakanoshima, Kita-ku, Osaka, 530-0005, Japan
Opening Date: January 13, 2026
With a deep-rooted philosophy of serving society since its founding in 1893, Moritaka Jindan continues to evolve and expand its product portfolio inspired by its foundational principles. The opening of the Jintan Laboratory at Nakanoshima Qross is a testament to their forward-thinking vision, marking a new chapter in their commitment to enhancing public health through innovation.
Background of Jintan Laboratory
The establishment of the Jintan Laboratory arises from a keen understanding of the challenges faced in previous research operations. Historically, Moritaka Jindan's research and development were primarily centered around the Osaka Tech Center, utilizing various external labs based on specific experimental needs. However, this resulted in a fragmented approach that hindered synergy. The decision to create a consolidated research hub at Nakanoshima Qross aims to streamline operations, fostering a collaborative environment that accelerates the development of innovative healthcare products.
This new state-of-the-art laboratory is equipped with a wet lab capable of handling human-derived samples, such as fecal matter, which is essential for conducting relevant and practical research that mirrors actual human intestinal conditions. This capability will augment the company's efforts to pursue deeper insights into gut health, forming the basis for developing evidence that supports their functional ingredients and product lines.
Strategic Evolution at Jintan Laboratory
Moritaka Jindan has formulated three strategic pillars that encapsulate the vision of the Jintan Laboratory:
1. Deepening Research and Development: The lab will enable research utilizing human-derived samples, allowing for analyses under realistic conditions that lead to robust evidence accumulation. By continuing to refine technologies and augmenting intellectual property strategies, Moritaka Jindan seeks to enhance its unique value proposition in the healthcare market.
2. Maximizing Synergies: The concentration of R&D resources at the Jintan Laboratory will accelerate the establishment of evidence and product development. The synergy between the company's core brands, such as Bifina and Choutek Series, will be enhanced through collaborative efforts that enable more efficient resource utilization and accelerated development timelines, ensuring a competitive edge in product offerings.
3. Open Innovation and Collaborative Synergy: Positioned within the Nakanoshima Qross, a hub for next-generation healthcare innovations, the Jintan Laboratory will engage in open innovation efforts with various startups and institutions housed within the facility. This collaborative ecosystem fosters cross-industry interactions, which are vital for pioneering unique healthcare solutions that Moritaka Jindan alone might not achieve.
Commitment to Innovation
Eiji Ishida, the Executive Officer of R&D, has expressed enthusiasm about the new laboratory's potential. He emphasized that consistent experimentation and foundational research are vital sources of innovation. With a clear mission to enhance people's health and contribute positively to societal development, the Jintan Laboratory is set to challenge the boundaries of healthcare technology. Moritaka Jindan is resolute in its approach, maintaining high standards of dedication and resilience in its pursuit of groundbreaking advances.
Facilities Overview
Name: Jintan Laboratory
Location: Nakanoshima Qross Mitsui Link Lab, 4-3-51 Nakanoshima, Kita-ku, Osaka, 530-0005, Japan
Opening Date: January 13, 2026
With a deep-rooted philosophy of serving society since its founding in 1893, Moritaka Jindan continues to evolve and expand its product portfolio inspired by its foundational principles. The opening of the Jintan Laboratory at Nakanoshima Qross is a testament to their forward-thinking vision, marking a new chapter in their commitment to enhancing public health through innovation.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.